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Objectives: Inappropriate medication prescribing is a recognized clinical problem in 
nursing home residents of whom many have polypharmacy. However, results about the 
effectiveness of medication reviews targeted at improving prescribing and deprescribing 
have been equivocal. We therefore examined barriers and facilitators of conducting 
medication reviews.
Method: We purposively sampled medication reviews to capture salient barriers and 
facilitators of conducting medication reviews both in nursing home care units for dementia 
and disabling conditions. We held semi-structured interviews about consecutive steps of 
medication reviews. Interviews were transcribed verbatim and analyzed with the “method 
of constant comparison.”
Results: Six nursing home residents/relatives of nursing home residents, 8 elder care 
physicians, 5 pharmacists, and 10 nurses took part in the semi-structured interviews. 
We observed four overarching themes of barriers and facilitators: “realizing fidelity of the 
patient perspective (theme 1),” “level of comprehensiveness of medication reviews (theme 
2),” “inclinations of healthcare providers (theme 3),” and “inter-professional collaboration 
and alliances (theme 4).” Theme 1 “realizing fidelity of the patient perspective” referred to 
the observation that assessing the patient perspective was a delicate balance between the 
value and the impediments of a proper assessment of the patient perspective. Theme 2 
“level of comprehensiveness of medication reviews” reflected the struggle of practitioners 
to find an optimum between medication reviews being both comprehensive and feasible. 
Theme 3 “inclinations of healthcare providers” concerned setting intervention targets that 
were complementary to the practices of physicians and keeping the pharmacist blind to 
the patient perspective as a countermeasure to physicians’ inclinations. Finally, theme 
4 “inter-professional collaboration and alliances” highlighted mutual support and inter-
professional collaboration to strengthen healthcare practitioners’ contributions.
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INTRODUCTION
Inappropriate medication prescribing is a recognized clinical 
problem in nursing home residents of whom many have 
polypharmacy. Up to 40% of nursing home residents have ≥1 
inappropriate medications prescribed (Gallagher et al., 2007). 
Medication reviews have been examined as an intervention 
strategy to improve prescribing, (Holland et al., 2005; 
Zermansky et al., 2006; Gillespie et al., 2009; Patterson et al., 
2010; Frankenthal et al., 2014; Wallerstedt et al., 2014; Meid et al., 
2015) but findings about their effectiveness have been equivocal 
(Alldred et al., 2016). Recently, we conducted the Discontinuing 
Inappropriate Medication in Nursing Home Residents (DIM-
NHR) study, a pragmatic cluster randomized controlled trial 
(RCT) (Wouters et al., 2017). The aim of the DIM-NHR study 
was to examine successful discontinuation of inappropriate 
medication use and to improve prescribing in nursing home 
residents with Multidisciplinary Multistep Medication Reviews 
(3MR). 3MR medication reviews were carried out by elder 
care physicians in collaboration with pharmacists and nursing 
staff. 3MR medication reviews involved an assessment of the 
patient perspective and medical information, drug reviewing, 
a multidisciplinary meeting by elder care physicians and 
pharmacists to arrive at pharmacotherapeutic actions, and the 
actual execution of these actions. Results demonstrated that 3MR 
medication reviews were effective in discontinuing inappropriate 
medication use in nursing home residents.
Medication reviews, such as the 3MR, can be considered 
complex healthcare interventions because they consist of 
consecutive steps and are usually conducted by an inter-
professional team (Craig et al., 2008). As such, complex healthcare 
interventions are difficult to evaluate with solely quantitative 
methods, hence qualitative research may be worthwhile to 
conduct. Qualitative analysis is likely to shed light on the barriers 
and facilitators of consecutive steps of medication reviews 
(2016). Insights from qualitative research into challenges have 
the potential to improve the success rate of medication reviews 
in nursing homes as well as other relevant care settings for older 
geriatric patients. Inadequate dealing with different barriers and 
not optimally using facilitators is likely to have caused the results 
of previous studies to be equivocal. Barriers and facilitators are 
expected to occur with regard to two central components of the 
medication review process, namely, patient involvement and 
inter-professional collaboration. Patient involvement is important 
to provide healthcare according to the ethical principles of 
“beneficence,” “non-maleficence,” “patients’ autonomy,” and 
“justice” (Reeve et al., 2016). However, more knowledge is needed 
about barriers and facilitators of incorporating the patient 
perspective and shared decision-making as part of medication 
reviews. It has not yet been widely examined how and to what 
extent nursing home residents, of whom many have dementia 
and cognitive impairment, could be involved in decision-making 
about prescribing (Reeve et al., 2016). Furthermore, regarding 
inter-professional collaboration, there is a paucity of knowledge 
about the mutual perceptions of physicians, pharmacists, and 
nursing staff about each other´s roles and duties in conducting 
the consecutive steps of medication reviews, and in deciding on 
and executing of changes. In addition to the previously published 
quantitative evaluation (Wouters et al., 2017), we therefore also 
embedded a qualitative study in the DIM-NHR cluster RCT.
Accordingly, the aim of this qualitative study was to 
examine the barriers and facilitators of conducting medication 




Between September 2014 and January 2016, we conducted a 
qualitative study following established methods (Miles and 
Huberman, 1994) and the “Consolidated Criteria for Reporting 
Qualitative Research” (COREQ) recommendations (Consolidated 
criteria for reporting qualitative research (COREQ), 2016). 
We utilized in-depth, semi-structured interviews to research 
the medication review experiences of nursing home residents 
(or their representative) and their physician, pharmacist, and 
nursing staff. Interviewees were selected from DIM-NHR study 
participants. Nursing home residents were included in the DIM-
NHR study if they had a life expectancy that was greater than 4 
weeks. Elder care physicians were eligible for entry into the DIM-
NHR study if they were responsible for dementia special care 
units or care units for disabling conditions. Details of the DIM-
NHR study have been described elsewhere (Wouters et al., 2017).
We adopted purposive sampling to uncover salient problems 
that were likely to be encountered while conducting medication 
reviews. We therefore selected the medication reviews conducted 
for nine nursing home residents that reflected diversity in 
Discussion: These themes of barriers and facilitators emphasize the need to improve 
meta-communication during the medication review process. This pertains to the need 
for healthcare providers to appraise the fidelity of the patient perspective in a dialogue 
with residents/relatives. Furthermore, discourse between healthcare practitioners is 
needed beforehand about the level of comprehensiveness intervention targets, and 
inter-professional collaboration.
Keywords: polypharmacy, inappropriate prescribing, semi-structured interviews, deprescribing, geriatrics, 
qualitative study, inter-professional collaboration, medication reviews
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terms of the nursing home residents’ sex, reason for admission 
(dementia or physical disability), and number and type of 
prescribed medications. We approached the treating elder care 
physician and the pharmacist involved in the medication review, 
a member of the nursing staff, and the selected nursing home 
resident (or their representative, usually a family member, 
in cases were the nursing home resident was incapacitated). 
Nursing home residents were interviewed in their own room (or 
their representative in their own home). Healthcare professionals 
were interviewed individually in their own offices.
Data Generation
All interviews were conducted by HW, a male researcher with 
experience in conducting qualitative research, with knowledge of 
polypharmacy, medical decision-making, and patients’ attitudes 
toward medication use, geriatrics and gerontology, and cognitive 
function. Most of the participants had met HW at least once 
prior to the interview and were aware that he was one of the 
DIM-NHR study trialists. Interviews were expected to last 1 h 
and were audio recorded. Field notes were also made.
Interview Guide of Semi-Structured 
Interviews
The interview guide was developed during multiple rounds of 
discussion between HW, FB, and KT. The interviews concerned 
the four consecutive steps of the 3MR (see Table 1): “assessing 
patient perspective and medical information (step  1),” 
“drug reviewing (step 2),” “multidisciplinary meeting and 
pharmacotherapeutic actions (step 3),” and “execution and 
evaluation of pharmacotherapeutic actions (step 4).” Step 1 
reflected the patient involvement in medication reviews. Steps 
2–4 reflected inter-professional collaboration by physicians, 
pharmacists, and nursing staff. Each interview ended with 
a reflection on issues discussed and potential omissions. 
To identify both expected and unexpected barriers and 
facilitators of conducting medication reviews as specifically 
as possible, healthcare providers were prompted at the 
beginning of the interview by presenting them the medication 
review that had been selected by the research team. To that 
end, HW reminded healthcare providers about the specific 
pharmacotherapeutic problems that had been encountered 
during the medication review.
Qualitative Analysis
Audio-recorded interviews were transcribed verbatim by AE, 
a pharmacy intern. Transcripts were anonymized by replacing 
the participant’s name with a pseudonym (a bird name) and 
were subsequently entered into NVivo version 10.0 to aid data 
management and coding. Coding was done in an iterative fashion 
to allow the above described interview guide to evolve on the 
TABLE 1 | Interview questions about the four consecutive medication review steps.
Steps and key questions
#1 Assessing patient perspective and medical information
To physicians and pharmacists: Was it possible to assess this nursing home resident’s or their relative’s preferences and experiences? All interviewees: How self-
evident is it that the physician knows these? And what about the pharmacist? If pharmacists would be uninformed, what would be solutions e.g., pharmacists 
could visit the ward to get an impression of nursing home residents. All interviewees: To what extent does the patient perspective need to be documented? In 
what way should the patient perspective be assessed? How importance is it that you/a nursing home resident know(s) why they use a medication and how they 
use it? How important was it that the physician was informed about your/the nursing home resident’s perspective, physical health, medical history, lab values, 
and allergies prior to the medication review? And what about the pharmacist? What are advantages and disadvantages of informing the pharmacist about the 
patient perspective and medical information? Would it be important to make a selection of nursing home residents e.g., referring patients with complex problems 
and not doing reviews for patients who barely use medications or not at all? 
#2 Drug reviewing
All interviewees: How important was the use of START/STOPP (Gallagher et al., 2008) and Beers Criteria (American Geriatrics Society 2012 Beers Criteria 
Update Expert Panel, 2012) (an example was given to clarify the criteria to nursing home residents/relatives and nursing staff). How useful are these criteria for 
clinical practice? To physicians and pharmacists: Was it possible to adhere to these criteria for this nursing home resident? Why or why not? Do you consider 
all medications for which there is a Beers or STOPP criterion inappropriate? Do the STOPP and Beers Criteria differ from each other? Is there other scientific 
research/knowledge through the Dutch College of Elder Care Physicians or the Dutch College of available? Were previous pharmacotherapy audit meetings 
useful? How important was this preparation by the pharmacist for the next step? 
#3 Multidisciplinary meeting and pharmacotherapeutic actions
All interviewees: How valuable was the meeting with the physician/pharmacist for this patient? Where should medication reviews be targeted at? For weighing 
the benefits and drawbacks of medications? For undertreatment or overtreatment? Are intermediate screenings valuable? Is the meeting a screening of problems 
or the best time to actually reach final decisions? What about medication errors? Would you like a nursing staff member/yourself to attend these meetings? What 
is important to pay attention to when it comes to one’s professional attitude? 
#4 Execution and evaluation of pharmacotherapeutic actions
To pharmacist physician and nursing staff: How did you agree with the physician/pharmacist about specific appointments for this nursing home resident? To 
relatives/nursing home residents: Did you hear about specific arrangements by the physician and pharmacist about your medication? All interviewees: How can 
you ensure that physicians actually provide feedback about these appointments to the pharmacy? Who is responsible for executing the changes? Which role do 
the nursing staff need to play during the execution? Is it important to inform or to consult family? What is the utility of asking the family? Do you inform patients 
about possible side effects after initiating a medication? Do you tell them about possible withdrawal effects? How does one need to organize medication reviews 
to obtain better results for this patient? Do the medication reviews take place with sufficient frequency? Are pharmacotherapy audit meetings useful for execution 
of changes? 
START, screening tool to alert doctors to right treatment; STOPP, screening tool of older persons’ potentially inappropriate prescriptions.
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basis of new insights from consecutive interviews. The method of 
“constant comparison” was used for coding thereby expanding an 
initially defined coding tree with superordinate and subordinate 
themes. After coding of nine interviews, HW applied “coding on” 
by reviewing the initial codes for consistency and adequacy.
In order to reduce bias in the analysis process and to enable 
reflexivity, codes were regularly reviewed and discussed with 
co-authors AE as well as with FB, an elder care physician, and KT, 
a professor of clinical pharmacy. Charting was applied and rival 
explanations investigated to assist interpretation. Specifically, we 
constructed “role-ordered matrices,” one per medication review 
step. These were cross-tables with transcript fragments ordered 
according to type of interviewee i.e., nursing home resident/
representative, physician, pharmacist, or nursing staff (in adjacent 
columns) and codes (in rows beneath each other). This enabled an 
examination of consensus and discrepancy among and between 
pharmacists, elder care physicians, nursing staff, and relatives of 
nursing home residents with regard to the consecutive steps of 
the medication reviews. For that goal, interviewees’ responses 
were paraphrased while maintaining a coding link to their raw 
statements. In multiple reviews of the data, most salient quotes 
were chosen. We also examined links between codes by studying 
overlap between them, interviewees’ reflections, and field notes. 
Saturation was achieved as no new themes came to the fore.
Ethics
The medical ethical committee of the University Medical 
Center of Groningen approved the study (protocol number 
NL48091.042.14). Written informed consent was asked from 
nursing home residents in wards for disabling conditions if they 
were deemed capable by the nursing staff. Informed consent from 
a legal representative was asked for nursing home residents who 
were not capable of providing informed consent and for those 
from dementia special care units.
RESULTS
A total of 9 nursing home residents, 9 elder care physicians, 
5 pharmacists, and 10 nurses were involved in the conduct of 
the 9 selected medication reviews. Of the nine nursing home 
residents/representatives, six participated (one representative 
declined the interview, one representative declined due to family 
circumstances, and one nursing home resident passed away). 
Of them, four were representatives, and two were nursing home 
residents. Of the nine elder care physicians, eight participated (one 
was unavailable during the study period). All pharmacists and 
nurses participated. A total of 32 semi-structured interviews were 
conducted. Sampling by medication review characteristics led to 
diversity in medications reviewed as these included psychotropic, 
cardiovascular, respiratory, analgesic, anti-coagulant, and bone 
affecting agents (Table 2) as well as interviewees’ characteristics 
(Table 3). In the initial phase of the analysis, the facilitators and 
barriers were recorded for each consecutive step of conducting 
medication reviews (Figure 1). Further analysis identified four 
overarching themes which described the barriers and facilitators 
to conducting medication reviews.
Theme 1: Realizing Fidelity of the Patient 
Perspective
In step 1 of the medication review, it became clear that realizing 
fidelity of the patient perspective in the medication review 
process (i.e., correctly assessing and incorporating nursing home 
residents’ or relatives’ viewpoints) proved to be a delicate balance 
between facilitators and barriers. The facilitators included the 
utility of the patient perspective as a leverage to decide on which 
medications to focus on in cases where an extensive number of 
medications were prescribed, for tailoring the pharmacist’s advice 
to the physician, and to psychologically prepare nursing home 
residents or their relatives for medication changes. Importantly, 
there could be discordant views on medications, with clinical 
guidelines designating medications as inappropriate, and 
candidates for discontinuation, while patients considered them 
to be needed:
“The question is whether these medications are 
inappropriate for this nursing home resident. He has end-
stage COPD and has already lived longer than expected. He 
also makes a deliberate choice to have the least amount of pain 
and bother. I would not wish this combination of medications 
on anybody.” [Swan, physician discussing case 1165)
Important barriers to involving the patient became evident as 
well. As expected, a barrier to acquiring a reliable understanding 
of the nursing home resident’s perspective was their cognitive 
impairment. In such cases, an important strategy for physicians 
was to apply consistent gauging to assess the nursing home 
resident’s viewpoint:
“You always try to verify nursing home residents’ answers. 
By checking the response you received and the consistency 
between answers after repeating your question … But also by 
coming back to repeat the same conversation, or verifying your 
opinion with the family or the nursing staff …” [Cormorant, 
physician discussing case 1250]
Grief was also a barrier to involving the nursing home 
resident’s or their family’s perspective. This came to the fore 
in an interview with a spouse of a recently admitted nursing 
home resident:
I am having a very difficult time with this. She does not 
seem to be my wife anymore. I do not want her to die … 
please understand me correctly … but it makes a difference. 
I cannot judge her joy in life … but from my point of view, 
living in a nursing home would be a nightmare. [Buzzard, 
spouse discussing case 1439]
It was also exemplified by the following statement from 
a member of the nursing staff in relation to a nursing home 
resident who experienced the loss of a limb:
“We are very careful with this nursing home resident … 
You always ask her what she wants and what she still can 
do. This woman is also going through the whole process of 
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accepting [her leg amputation], which also confuses her 
entirely. What a misery”. [Eagle, nurse discussing case 1250]
The submissive behavior of some nursing home residents/
representatives could also be a barrier hampering healthcare 
professionals’ understanding of the patient perspective. Nursing 
home residents/representatives often did not expect to be 
involved in the medication review process and preferred to trust 
their physician’s advice:
“I don’t think my mother has ‘preferences.’ She has always 
been very compliant in swallowing what was prescribed to 
her. Perhaps because of too little knowledge. Perhaps it is 
the generation who simply does what the doctor prescribes 
TABLE 2 | Overview of nine nursing home resident cases discussed in semi-structured interviews.
1019 Description: Despite the many medications prescribed, the nursing home resident (male, 75 years) is stable now. Therefore, the physician believes it 
undesirable to discontinue any medications. There are four medical specialists involved. Discontinuation of medications is not in line with the view of the 
nursing home resident’s spouse, who is highly involved in the care of the nursing home resident and who opposes discontinuation of medications. The 
nursing home resident is treated with amitriptyline, which is undesirable; yet, the physician believes that amitriptyline causes little harm and that an SSRI 
would not be sufficiently effective as an alternative. However, the pharmacist observes that the dosing is three times higher than expected, and the physician 
will therefore critically reappraise the dose. Number of medications prescribed: 14. Discussed medications: psycho-analeptics. Discontinued/dose 
adjusted: yes, dose lowering of amitriptyline. Care unit: for dementia
1121 Description: The pharmacist recommends considering the discontinuation of statins (prescribed for high cholesterol) for this nursing home resident (female, 
76 years). The physician agrees with this as statins may not be beneficial. However, in general, he finds it difficult to discontinue statins in every nursing home 
resident. Number of medications prescribed: 12 Discussed medications: lipid-modifying agents. Discontinued/dose adjusted: no change. Care 
unit: for dementia
1165 Description: This nursing home resident (male, 67 years) has severe neuropsychiatric problems. So far, all attempts to discontinue any drug have failed. 
There are several medical specialists involved including a psychiatrist, a pulmonologist, and a cardiologist, who may be reluctant to discontinue medication. 
The psychiatrist, for instance, does not want the medications for compulsions and anxiety to be discontinued. Perhaps, this nursing home resident is too 
complex to discontinue medication. Number of medications prescribed: 29. Discussed medications: diuretics, corticosteroids for systemic use, thyroid 
therapy, mood stabilizers, antidepressants, drugs for the respiratory system. Discontinued/dose adjusted: fluvoxamine discontinued. Care unit: for 
disabling conditions
1250 Description: This nursing home resident (female, 91 years) underwent a leg amputation. She experiences a lot of pain (both ischemic and osteomyelitic 
pain and necrotic pain) in the right foot. Of course, she does not want another amputation. Tramadol and duloxetine were prescribed for neuropathic pain 
after the amputation. The pharmacist recommends to reduce the dose of paracetamol that was started before duloxetine, but the physician does not believe 
this to be possible. The pharmacist also does not wish to discontinue duloxetine because it is difficult to differentiate between isschemic and neuropathic 
pain. The nursing home resident is also treated with gabapentin for neuropathic pain. Furthermore, the pharmacist recommends to discontinue statins. The 
cholesterol values are satisfactory, and statins may not be beneficial. The physician agrees with discontinuing statins and will discuss this with the nursing 
home resident. Vitamin D and calcium have not yet been started, because the physician wants to await stabilization of the nursing home resident’s condition. 
However, the elder care physician believes that the nursing home resident will soon pass away. Number of medications prescribed: 15. Discussed 
medications: analgesics, lipid-modifying agents. Discontinued/dose adjusted: lipid-modifying agents discontinued. Care unit: for disabling conditions
1333 Description: The nursing home resident (female, 86 years) has a large amount of sleeping medications including flurazepam, oxazepam, and temazepam. 
However, the nursing home resident is reluctant to discontinue any of these medications. She is very anxious to sleep badly. Both the physician and the 
pharmacist agree that it would be a good idea to discontinue the flurazepam. However, the tapering off of this drug needs to be done in a prudent manner, 
because it works longer and is more lipophilic. The elder care physician says the nursing home resident is never drowsy. The pharmacist still warns that there 
is an increased fall risk as this nursing home resident often uses a wheel chair to move around. The elder care physician asks advice on whether and how to 
switch from flurazepam to an alternative drug in case he decides to taper this drug. The pharmacist will provide detailed advice. As a start, the pharmacist 
believes it is best to first taper off medications to lower dosages. Number of medications prescribed: 18. Discussed medications: anxiolytics. 
Discontinued/dose adjusted: flurazepam discontinued. Care unit: for disabling conditions
1360 Description: This nursing home resident (female, 96 years) is treated with venlafaxine. The pharmacist asks if there is an indication for this drug, and 
whether the nursing home resident has depression. The elder care physician confirms depression but thinks that, since the patient has moved to a nursing 
home, much of the previously experienced distress may have disappeared, thereby making venlafaxine redundant. The pharmacist wonders whether 
paracetamol is still needed. The physician confirms the necessity of paracetamol as the nursing home resident has painful legs. Finally, the pharmacist asks if 
vitamin D and bisphosphonates should be initiated. However, the physician does not believe this to be useful, since the nursing home resident is not mobile. 
Number of medications prescribed: 5. Discussed medications: antidepressants, medications for bone diseases. Discontinued/dose adjusted: 
no change. Care unit: for dementia
1415 Description: This nursing home resident (male, 91 years) has had a stroke, has edema, pain, a dry mouth, and a pulmonary embolism. The nursing home 
resident was initially treated with acenocoumarol because of atrial fibrillation. However, owing to fall risk and increased risk of bleedings the nursing home 
resident was switched to acetylsalicylic acid and dipyridamole. The patient is still somewhat mobile and can walk. Owing to the nursing home resident’s 
age and decline, re-initiating acenocoumarol is no longer indicated. Omeprazole is prescribed as a gastroprotective agent because of the prescribing of 
acetylsalicylic acid. Paracetamol may be discontinued. Number of medications prescribed: 8. Discussed medications: antithrombotic agents, diuretics, 
medications for peptic ulcer, and gastro-oesophageal reflux disease. Discontinued/dose adjusted: this patient became deceased before he or his family 
could be interviewed. Care unit: for disabling conditions
1439 Description: This nursing home resident (female, 79 years) uses no medications at all. She has dementia, but she is vital, and her lab values are satisfactory. 
Number of medications prescribed: 0. Discussed medications: not applicable. Discontinued/dose adjusted: not applicable. Care unit: for dementia
1823 Description: This nursing home resident (female, 88 years) has a history of orthostatic hypotension, hypertension, stroke, and Bowen’s disease. Lab 
values including thyroid gland function were normal. The nursing home resident is also treated with paracetamol for back pain and macrogol to improve 
sleeping. She has a blood pressure of 130/72. She is treated with spironolactone and a thiazide. The physician finds it difficult to comprehend this treatment 
combination of spironolactone and thiazide. The physician will clarify the rationale for this treatment combination and determine the blood pressure again. 
Number of medications prescribed: 10. Discussed medications: antithrombotic agents, diuretics. Discontinued/dose adjusted: spironolactone and 
thiazide discontinued. Care unit: for disabling conditions
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without questioning.” [Duck, daughter of nursing home 
resident discussing case 1250]
This expectation was possibly related to a lack of knowledge as 
confirmed by another representative:
“My mother sometimes expresses reluctance to take a 
medication, but she does not know what the medication is 
prescribed for and she cannot appraise this. What do I need to 
imagine when it comes to preferences? Suppose, I would apply 
this to myself. I also have several medications. Preference for 
one medication over another requires you to be informed 
about your medications, which I am not.” [Crane bird, son of 
nursing home resident discussing case 1360].
Establishing the nursing home resident’s perspective was 
mainly seen as the role of the physician, but fragmented care, 
particularly less regular contact with nursing home residents, 
was perceived as a barrier to the physicians knowing the patient 
perspective well enough:
“I do not exactly know about every nursing home resident’s 
preferences. This has to do with the presence of many other 
physicians and that you do not see the nursing home residents as 
often as you used to see them”. (Raven, physician about case 1121)
Theme 2: Level of Comprehensiveness 
of Medication Reviews
In step 2 of the medication review, the “level of 
comprehensiveness of medication reviews” was an important 
theme that concerned the need to find an optimum between 
comprehensiveness and feasibility. Pharmacists considered 
published tools such as the START (screening tool to alert 
doctors to right treatment), STOPP (screening tool of older 
persons’ potentially inappropriate prescriptions) (Gallagher 
et al., 2008), and Beers Criteria (American Geriatrics Society 
2012 Beers Criteria Update Expert Panel, 2012) as facilitators 
of medication reviews. Pharmacists described them as useful 
educational tools and good reminders to detect potential 
medication-related problems. A barrier, however, for physicians 
and nursing staff was the lack of their familiarity with these tools. 
Moreover, physicians explained that some of these tools may use 
an overly comprehensive set of criteria which tended to result in 
an overload of potentially inappropriate medication alerts:
“If you strictly adhere to the Beers criteria, you will get 
many alerts. In the past we discussed some of the alerts with 
the pharmacists and requested them to omit these alerts, 
as we did nothing with them.” [Swan, physician discussing 
case 1165]
This was confirmed by a pharmacist who knew from 
experience that recommendations from these tools could not 
always be implemented in practice:
“I have done so many reviews. …. And you know indeed 
that you should discontinue temazepam, but in practice you 
know it will not succeed. Well in your head, you notice them, 
but you do not always act according to these criteria.” [Magpie, 
pharmacist discussing case 1823]
Related to this was the need to also consider the adaptation 
of guidelines to individual patients as acknowledged by one 
of the representatives:
“Yes … it is excellent that there are guidelines for medications 
and to administer medications at an optimal dose. At the same 
time, adaption of a dose to the individual person is of utmost 
importance as well. Setting the dose of haloperidol according 
to the guidelines suited the needs of m+y partner well and she 
thrived on it as there is a stable situation now. However, I also 
heard a story of an 85-year old resident who was prescribed 
haloperidol for the first time and could not get out of bed 
anymore” [Hummingbird, spouse discussing case 1121].
Theme 3: Inclinations of 
Healthcare Providers
In steps 1–3 of the medication review, inclinations i.e., usual 
practices and habits of physicians, pharmacists, and nursing staff 
were observed. Pharmacists seemed to lack confidence in making 
judgments about the patient perspective because they felt they 
were too far removed from the patients. While this seemed to be 





N 6 * 5 ** 8 § 10 †
Age, M (SD) 78 (10) 42 (12) 46 (13) 43 (10)
Female, n 4 2 2 9 
No. of prescribed medications, median (range) 12 (8) − − ‡ − − ‡ − − ‡
>10 years of working experience, n − − ‡ 3 4 9
*Of the 9 nursing home residents/representatives, 6 agreed to participate, 1 representative declined the interview, 1 representative declined due to family circumstances and  
1 resident passed away; 4 were representatives and 2 were nursing home residents.
**1 pharmacist conducted 3 medication reviews, 2 pharmacist conducted 2 medication reviews each, and 2 pharmacists conducted 1 medication review each.
§Of the 9 elder care physicians, 8 participated, 1 was unavailable during the study period.
†1 additional member of the nursing staff was involved in the interview about the medication review of case 1823.
‡Not applicable.
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a barrier at first glance, some physicians actually saw this relative 
distance as a facilitator, since it allowed the pharmacist to assess 
the situation more impartially and to proactively counteract 
physicians’ inclinations:
“It may be a good idea to let someone, who does not 
know anything about the situation [such as the pharmacist], 
critically appraise the medication use and patterns and to 
let them learn only afterwards about the reasons for certain 
choices.” [Cormorant, physician discussing case 1250]
Different inclinations were also observed with respect to 
knowledge of nursing home residents’ medical history. During 
the DIM-NHR study, pharmacists had routine access to nursing 
FIGURE 1 | Overview of facilitators and barriers for the four 3MR medication review steps.
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home residents’ medical charts, which is uncommon in usual care. 
Pharmacists highly valued receiving this medical information 
as part of the trial as it served as a facilitator to conducting 
medication reviews. They felt they were better able to tailor their 
advice to the individual patient; it saved time, and they were less 
liable to their own inclination of inferring diagnostic indications 
from medications:
“To me having the medical history on paper is of utmost 
importance. It really saves a lot of discussion time with the 
physician. Otherwise, I tend to ask questions, because you 
adopt a reversed tactic and you try to infer the indication 
from the medication (…).” [Bittern, pharmacist discussing 
case 1250]
This valuing by pharmacists was confirmed by the 
representatives of nursing home residents:
“It is not necessary for pharmacists to know everything, 
but it would be important to know what is wrong with 
someone, what kind of medications are prescribed for their 
conditions and whether everything connects with anything. 
If they would know this, this would earlier sound the alarm 
bell, because a physician does not know this [Duck, daughter 
of nursing home resident discussing case 1250].”
In contrast, a potential barrier for pharmacists was that 
physicians thought that pharmacists should infer the indication 
from the medication and need not have access to nursing home 
residents’ medical charts:
“A pharmacist talks from a different angle and they 
should not sit on our chairs in my opinion. … We have more 
profound clinical knowledge. We just expect them to judge 
whether combinations of medications we prescribe are 
possible. And we are the ones who study the nursing home 
resident’s diseases, while the pharmacist infers diseases from 
the nursing home residents’ medication use.” [Swan, physician 
discussing case 1165]
Inclinations of physicians bared important implications for 
setting intervention targets of medication reviews. Efficacious 
targets were preferably complementary to the usual practices 
of physicians. Physicians considered medication reviews 
particularly useful for reducing overtreatment rather than 
undertreatment owing to their tendency toward starting rather 
than stopping medications:
“Physicians tend to put more emphasis on undertreatment 
than on overtreatment. Starting medication is perceived 
by physicians as something active whereas discontinuing 
medication is not. That is an inclination I think. Of course, 
you know you also have to do something about overtreatment 
but when you are rushing around, it intuitively feels more 
problematic when you do not start a medication rather than 
forgetting to discontinue another one.” [Raven, physician 
discussing case 1121]
Another reason why medication reviews were considered 
useful for reducing overtreatment may be explained by a view 
among physicians that undertreatment is less clinically relevant 
than overtreatment:
“What chance is there that nursing home residents 
experience a medical problem as a result of undertreatment, 
because their life expectancy is so short?… This is what I use 
medication reviews for: Which blood pressure medications 
do people have? If there are three, I give it a sharp look to 
consider whether a drug can be discontinued.” [Pheasant, 
physician discussing case 1360]
Sometimes, medication changes were executed immediately. 
In other cases, decisions were postponed. A barrier observed by 
one pharmacist that particularly related to the case of postponed 
decisions was the seemingly variable impact or utility of their 
discussions with elder care physicians:
“There are different physicians, and different kinds of 
discussions. For some physicians you notice that they literally 
adjust the drug prescriptions behind their computers and you 
see that they follow your advice, whereas other physicians 
nod a few times and make notes in a notebook (…).” [Stork, 
pharmacist discussing case 1019]
A clear barrier was the lack of consensus on the extent to which 
nurses should also join the medication review meetings between 
pharmacists and physicians. One pharmacist thought nurses 
lacked pharmacotherapeutic knowledge and foresaw emotional 
involvement with patients as an undesirable inclination of nurses:
“You have to keep the medication review as clear as 
possible and you will also get more emotional input, rather 
than pharmacotherapeutic knowledge, because the nursing 
staff does not possess this knowledge.” [Bittern, pharmacist 
discussing case 1250]
However, another pharmacist thought that the information 
held by nursing staff was valuable for medication reviews:
“Well often initiation of medications is discussed [without 
the nurse being present]. But then, you do not know precisely 
if a patient has constipation, or difficulties with taking their 
medications. The physician does not always know this … The 
nursing staff does.” [Pelican, pharmacist discussing case 1439]
Nursing staff, however, thought it too time consuming to 
participate in the medication review discussions, which would 
be at the expense of their caring duties.
Theme 4: Inter-Professional Collaboration 
and Alliances
In steps 1 and 4 of the medication review, the importance 
of “interprofessional collaboration and alliances” between 
physicians, pharmacists, and nurses was demonstrated. Physicians 
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valued pharmacotherapy audit meetings with pharmacists held 
once every 6 weeks but which were not part of the 3MR. These 
meetings, in which physicians and pharmacists critically reflected 
on pharmacotherapeutic decisions and educated each other, were 
considered a facilitator for conducting medication reviews.
In the physician–nurse alliance, both nurses and physicians 
indicated that the key role of the nurses was to facilitate the 
implementation of medication changes. Nursing staff assisted 
physicians in signaling possible relapse and other problems, as 
well as communicating the medication changes with nursing home 
residents and/or their relatives by translating physicians’ jargon 
into lay language. This was confirmed by nursing home residents 
and representatives. For example, where the nurse was able to 
convey the physician’s commitment to deprescribing to the family, 
they would be more likely to agree with medication changes:
“Yes if the physician has a clear vision on stopping 
medication or tapering these, the family will follow their 
path. If the physician also considers it of utmost importance 
to be very critical about the medication, then that makes a 
difference of course.” [Canary, nurse discussing case 1121]
Beyond this, nurses felt they had additional roles to play in 
order to support elder care physicians with medication reviews. In 
circumstances in which the patient perspective would be difficult 
to assess, a facilitator offered by nurses was to carefully observe the 
nursing home residents’ behavior to verify the nature of the problem:
“The things that a nursing home resident [or his 
representative] tells you about are not always the things that 
bother them. (…) for example, in this case the resident’s spouse 
reports that he is in pain. However, we observe restlessness. 
… It is important to distinguish between the two.” [Parakeet, 
nurse discussing case 1019]
The importance of good inter-professional alliances was 
underlined by the observed barrier that physicians and 
nursing staff found it sometimes challenging to communicate 
discontinuation of medications with nursing home residents or 
their representative owing to the nursing home residents’ mental 
dependence on medications or associated emotional distress:
“She has fixed customs and has difficulty to accept change. 
So despite the insult to her memory function, there is always 
the possibility that when you discuss medication changes 
with her, she will become anxious about it, about what might 
happen to her.” [Pheasant, physician discussing case 1360]
Indeed, a physician suggested the formation of a physician–
pharmacist alliance to better support communication and 
acceptability of treatment discontinuation. If a pharmacist would 
show concordance with the physician’s decision-making, this may 
increase a nursing home resident’s or their relative’s confidence in 
review decisions:
“Suppose that people understand everything very well 
and that I have difficulty to convince them. Then it could be 
convenient to have the pharmacist at my side. In that case, 
I could say: would you like to join me some time? I have a 
critical patient with quite some preferences or specific drug 
related problems.” [Myna, physician discussing case 1333)
This was acknowledged by one of the representatives adopting 
a physician’s perspective while explaining his point of view:
“It would give additional authority to a decision. This 
decision is not only taken by me but also by the pharmacist. 
That sort of thing could carry a bit more weight.” [Crane bird, 
son of nursing home resident discussing case 1360].
DISCUSSION
This qualitative analysis of conducting medication reviews in the 
nursing home setting provided important insights into facilitators 
and barriers of patient involvement and inter-professional 
collaboration needed for conducting the consecutive steps of 
medication reviews. The facilitators and barriers observed in this 
study may help explain why findings about the effectiveness of 
medication reviews in reducing inappropriate prescribing were 
equivocal (Alldred et al., 2016) and may provide guidance for 
future improvement.
Theme 1: Realizing Fidelity of the Patient 
Perspective
With respect to incorporating the patient perspective in 
medication reviews, realizing fidelity of the patient perspective was 
found to be a delicate balance between a number of facilitators 
and barriers. Perceived facilitators of the patient perspective 
were an improved focus on which medications to target for 
change and also preparing patients psychologically for treatment 
adjustments. A notable observation here was that overprescribing 
could be partly guided by a nursing home resident’s values. 
This observation underlines the need to incorporate shared 
decision-making in order to weigh the ethical principle of 
“patients’ autonomy” against the other ethical principles of 
“beneficence,” “non-maleficence,” and “justice” when physicians 
and pharmacists appraise the appropriateness of medications. 
However, barriers in assessing the patient perspective were also 
evident. As expected, the patient perspective was often difficult 
to ascertain, particularly for patients with dementia or cognitive 
impairment. In these cases, a reported facilitator was the 
application of consistent gauging to verify the consistency of the 
patient perspective. Furthermore, the importance of adopting 
meta-communication, reflection, and expression of mutual 
expectations with nursing home residents and/or relatives was 
also highlighted for two circumstances. First, in addition to 
cognitive impairment, grief was found to be a barrier to involving 
the nursing home resident in medication reviews. Thus healthcare 
providers must come to appreciate that although nursing home 
residents may be eligible according to guidelines for a medication 
review, it would also be important to verify if they themselves 
are ready for it. Second, our findings demonstrated that patients 
may feel they lack sufficient knowledge to communicate their 
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preferences in medication reviews. Physicians should therefore 
emphasize the importance of nursing home residents’ (or their 
relatives) lay input to increase their confidence.
Some of our findings on patient involvement mirror those of 
previous studies. Inappropriate prescribing was found to depend 
in part on whether patients perceived their own medications 
as inappropriate (Reeve et al., 2013; Reeve et al., 2017). As one 
would expect, establishing patient preferences was found to be 
challenging in nursing home residents with cognitive impairment 
(Reeve et al., 2016). But in the present study, we also observed 
this to be difficult in case of grief. The consistent gauging strategy 
which came to the fore in this study seems to correspond with 
verification in an ongoing dialogue (Reeve et al., 2016). Our 
finding that nursing home residents were “submissive” or tended 
to rely on their physician’s judgment is consistent with paternalistic 
decision-making (Spinewine et al., 2005; Hughes and Goldie, 
2009) but, in this study, seemed mostly to originate from a lack 
of knowledge about medications among nursing home residents/
relatives. For conducting meta-communication dialogues and 
improving shared decision-making between physicians and 
nursing home residents, a previously proposed framework for 
shared decision-making with regard to deprescribing could be 
helpful (Jansen et al., 2016).
Theme 2: Level of Comprehensiveness of 
Medication Reviews
With respect to the comprehensiveness of medication reviews, 
it emerged that an optimum between comprehensiveness 
and feasibility was important given the likelihood that a 
redundancy of criteria of inappropriate prescribing would 
cause an overload of alerts for clinicians. A proactive strategy 
would therefore be to discuss beforehand whether a selection 
and or refinement of START/STOPP and Beers Criteria 
would be appropriate. These recommendations complement 
previous related findings showing that physicians thought 
START/STOPP (Gallagher et al., 2008) and Beers Criteria for 
medication analysis (American Geriatrics Society 2012 Beers 
Criteria Update Expert Panel, 2012) to be helpful but lacking 
evidence (Cornege-Blokland et al., 2012).
Theme 3: Inclinations of Healthcare 
Providers
There were a number of distinct inclinations of physicians, 
pharmacists, and nursing staff observed in this study. While 
pharmacists saw their relative distance from the patient 
perspective as a disadvantage, physicians saw pharmacists’ 
impartialness as beneficial in order to compensate for their 
own inclinations and background knowledge of patients. 
However, being at a distance from the medical history was a 
barrier for pharmacists leaving them to infer indications from 
medication prescriptions. Thus, physicians and pharmacists 
need to decide together where distance should be eliminated 
and where it should be maintained to optimize the medication 
review process. A related observation was that physicians were 
not always able to assess the patient perspective due to high 
workload and interruptions, as has been previously noted 
(Cullinan et al., 2015). This would support the observation 
that nursing staff can provide a greater role than mere 
implementation of treatment changes.
Furthermore, to increase the feasibility of reviews, 
the intervention targets of medication reviews should be 
complementary to physicians’ usual practice. Physicians 
awareness of their tendency to start medications rather than 
stop them may highlight the need to focus on overtreatment 
as a primary intervention target of medication reviews. 
This qualitative observation may actually explain the 
quantitative findings from the DIM-NHR study showing 
that 3MR medication reviews were effective in discontinuing 
inappropriate medication use, but not in initiating potentially 
underprescribed medications (Wouters et al., 2017).
Theme 4: Inter-Professional Collaboration 
and Alliances
While alliances between physicians and pharmacists seemed 
firmly established with respect to medication reviews, our 
findings indicated a lack of consensus between healthcare 
providers on the involvement of nurses. This requires attention, 
especially given the nurses’ potential contribution described by 
interviewees such as careful observation and insight into the 
patients’ perspective and lay translation of medical information 
which may facilitate the acceptability of treatment changes by 
nursing home residents/relatives. Pharmacists could further 
substantiate physicians’ treatment change decisions, especially 
in cases where nursing home residents have become emotionally 
dependent on medications. This mental dependence seems 
to relate to the persistent difficulty of deprescribing being 
interpreted by nursing home residents as an implicit sign that 
they are being given up on (Schuling et al., 2012). Altogether, 
our findings underline the importance to also adopt meta-
communication between healthcare providers. This is likely to 
foster a discussion about arrangements, the specificities of the 
processes, mutual expectations, and predefined agreements. 
This may prevent inertia (Reeve et al., 2017) and devolving 
responsibility or passing the responsibility from one healthcare 
professional to another (Kouladjian et al., 2016). To that end, our 
findings also suggested to embed medication reviews in existing 
pharmacotherapy audit meetings of physicians and pharmacists 
which are held to agree on prescribing guidelines and to discuss 
other pharmacotherapeutic issues.
Methodological Considerations
A number of methodological issues need to be addressed. 
Specific strengths of our study included the purposive sampling 
of salient medication reviews which was supported by the range 
of background characteristics including a variety of medical 
problems and types of medications, and the number of prescribed 
medications including one patient who used no medications 
at all. A related strength was that we interviewed all relevant 
stakeholders, i.e., nursing home residents (or their relatives), 
elder care physicians, pharmacists, and nursing staff. Thus, 
purposive sampling of medication reviews and conducting the 
interviews with these stakeholders may have contributed to the 
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breadth of barriers and facilitators as well as the identification of 
novel ones. Lastly, the rigorous reviewing of the codes as well as 
applying charting and “role ordered matrices” is likely to sustain 
that the present findings reflected key barriers and facilitators.
Possible limitations include the following. We could only 
include a relatively small number of nursing home residents/
representatives. We did not ask direct questions about barriers 
as this may have resulted in stating the obvious, e.g., complaining 
about work load, which would distract the physician/pharmacist 
from talking about more subtle clinical problems. Even more 
important was that we needed to be prudent. At the time of 
this research, there was much controversy about inappropriate 
prescribing in the media. Asking directly about barriers would 
have caused misinterpretation and frustration among clinicians 
and nursing staff. The fact that some pharmacists were involved 
in more than one review may also have given them a broader 
perspective than other pharmacists interviewed. Further, 
given their lesser involvement in medication reviews, nursing 
home residents and nursing staff may have perceived interview 
questions differently than pharmacists and physicians making 
mutual comparisons less straightforward. Lastly, we cannot rule 
out social desirability although healthcare professionals were 
interviewed confidentially and were open to discussing barriers.
CONCLUSION
Taken together, four key themes of salient barriers and facilitators 
of conducting medication reviews were identified. These require 
the need to improve meta-communication during the medication 
review process. This pertains to the need for healthcare providers 
to appraise the fidelity of the patient perspective in a dialogue 
with nursing home residents/relatives. Furthermore, discourse 
between healthcare practitioners is needed beforehand about 
the comprehensiveness and intervention targets of medication 
reviews as well as inter-professional collaboration. In turn, this 
has the potential to improve effectiveness of medication reviews 
aimed at the deprescribing of inappropriate medications in 
nursing home residents.
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